Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13/12/22 |
Amy M. McCord
LAW | General Counsel | - | 01/01/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02/08/13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23/08/23 |
Niraj Vasisht
BRD | Director/Board Member | 61 | 13/12/22 |
Michelle Yanez
BRD | Director/Board Member | 52 | 13/12/22 |
Michael Jerman
BRD | Director/Board Member | 40 | 24/05/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 172 023 545 | 71 400 692 ( 41,51 %) | 0 | 41,51 % |
Coordinate società
Inhibitor Therapeutics, Inc.
449 South 12th Street Unit 1705
33602, Tampa
+813 864 2562
http://www.inhibitortx.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |